Cite
Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators
MLA
Montserrat Ayala-Ramirez, et al. “Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators.” The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 3, Dec. 2010. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e1c7c73cf0c932704ca5568fe6354dd5&authtype=sso&custid=ns315887.
APA
Montserrat Ayala-Ramirez, Steven G. Waguespack, Nancy D. Perrier, Shamim Ejaz, Marcella M. Johnson, Lei Feng, Alexandria T. Phan, Thereasa A. Rich, Gilbert J. Cote, Camilo Jimenez, Naifa L. Busaidy, Shreyaskumar Patel, & Mouhammed Amir Habra. (2010). Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. The Journal of Clinical Endocrinology and Metabolism, 96(3).
Chicago
Montserrat Ayala-Ramirez, Steven G. Waguespack, Nancy D. Perrier, Shamim Ejaz, Marcella M. Johnson, Lei Feng, Alexandria T. Phan, et al. 2010. “Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators.” The Journal of Clinical Endocrinology and Metabolism 96 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e1c7c73cf0c932704ca5568fe6354dd5&authtype=sso&custid=ns315887.